UMIN ID: UMIN000012206
Registered date:05/11/2013
Evaluation of blood glucose and serum lipids lowring effects of teneligliptin in patients with type 2 diabetes mellitus
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Patients with type 2 diabetes mellitus |
| Date of first enrollment | 2013/11/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | teneligliptin 20mg per day for 12weeks |
Outcome(s)
| Primary Outcome | Blood pressure, LDL-c |
|---|---|
| Secondary Outcome | HbA1c, blood glucose, u-Na, s-Na, s-Cr, u-Cr, NT-proBNP, IRI, ANP, sLDL, metylglyoxal, CRP |
Key inclusion & exclusion criteria
| Age minimum | 20months-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1:contrandication to teneligliptin 2:Ineligible for this study |
Related Information
| Primary Sponsor | Wakayama medical University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | First department of internal medicine, WAkayama Medical University |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroyuki Ariyasu |
| Address | 811-1, KImiidera, Wakayama, Japan, 641-8509 Japan |
| Telephone | 073(447)2300 |
| ariyasu@wakayama-med.ac.jp | |
| Affiliation | Wakayama medical University First department of internal medicine |
| scientific contact | |
| Name | Hiroyuki Ariyasu |
| Address | 811-1, KImiidera, Wakayama, Japan, 641-8509 Japan |
| Telephone | 073(447)2300 |
| ariyasu@wakayama-med.ac.jp | |
| Affiliation | Wakayama medical University First department of internal medicine |